You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BAY94-8862

Showing 1 - 25 of 687
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure Trial in Mönchengladbach (BAY94-8862 (1.25mg), BAY94-8862 (2.5mg), BAY94-8862 (5mg))

Completed
  • Heart Failure
  • BAY94-8862 (1.25mg)
  • +4 more
  • Mönchengladbach, Nordrhein-Westfalen, Germany
    CRS Clinical-Research-Services Mönchengladbach GmbH
Jan 27, 2022

Clinical Pharmacology Trial in Neuss (Finerenone (BAY 94-8862) PEG solution, Finerenone (BAY 94-8862) immediate release tablet,

Completed
  • Clinical Pharmacology
  • Finerenone (BAY 94-8862) PEG solution
  • +3 more
  • Neuss, Nordrhein-Westfalen, Germany
    (unnamed)
Jan 27, 2022

Worsening Chronic Heart Failure, Chronic Kidney Disease Trial in Kiel (Finerenone (BAY94-8862))

Completed
  • Worsening Chronic Heart Failure
  • Chronic Kidney Disease
  • Finerenone (BAY94-8862)
  • Kiel, Schleswig-Holstein, Germany
    (unnamed)
Jan 27, 2022

Heart Failure Trial in Worldwide (BAY94-8862, Placebo, Spironolactone)

Completed
  • Heart Failure
  • BAY94-8862
  • +2 more
  • Linz, Oberösterreich, Austria
  • +49 more
Jan 27, 2022

Diabetic Nephropathies Trial in Japan (BAY94-8862, Placebo, BAY 94-8862)

Completed
  • Diabetic Nephropathies
  • BAY94-8862
  • +2 more
  • Nagoya, Aichi, Japan
  • +15 more
Jul 15, 2021

Called SMART-Finder to Look for People With Increased Amounts of

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Chronic Kidney Disease
  • Finerenone (Kerendia, BAY94-8862)
  • Type 2 DM drugs
  • Multiple Locations, Germany
    Many locations
Jan 13, 2023

Chronic Kidney Disease, Type 2 Diabetes Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))

Not yet recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes Mellitus
  • Finerenone (Kerendia, BAY94-8862)
  • Multiple Locations, India
    Many Locations
Jan 20, 2023

Worsening Chronic Heart Failure, Diabetic Nephropathy Trial in Kiel (Finerenone (BAY94-8862))

Completed
  • Worsening Chronic Heart Failure
  • Diabetic Nephropathy
  • Finerenone (BAY94-8862)
  • Kiel, Schleswig-Holstein, Germany
    (unnamed)
Jul 15, 2021

Called FLAMINgO to Learn More About Treatment Combination of

Active, not recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes
  • Finerenone (Kerendia, BAY94-8862)
  • Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
  • Whippany, New Jersey
    Bayer
Jan 19, 2023

Heart Failure Trial in Japan (BAY94-8862, Eplerenone, Placebo)

Completed
  • Heart Failure
  • BAY94-8862
  • +2 more
  • Seto, Aichi, Japan
  • +28 more
Jul 15, 2021

Diabetic Retinopathy Trial in Bulgaria, United Kingdom (Finerenone (BAY94-8862), Placebo)

Completed
  • Diabetic Retinopathy
  • Finerenone (BAY94-8862)
  • Placebo
  • Dimitrovgrad, Bulgaria
  • +10 more
Oct 31, 2022

Chronic Kidney Disease, Proteinuria, Children Trial in Multiple Locations (Finerenone (Kerendia, BAY94-8862))

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Finerenone (Kerendia, BAY94-8862)
  • Multiple Locations, Australia
  • +22 more
Aug 10, 2022

Diabetic Nephropathies Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
Has Results
  • Diabetic Nephropathies
  • Finerenone (BAY94-8862)
  • Placebo
  • Birmingham, Alabama
  • +146 more
Jun 30, 2021

Heart Failure Trial in Worldwide (Finerenone (BAY94-8862), Placebo, Inspra (eplerenone))

Completed
Has Results
  • Heart Failure
  • Finerenone (BAY94-8862)
  • +2 more
  • Birmingham, Alabama
  • +171 more
Jul 2, 2021

Lung Cancer Trial (ortataxel)

Completed
  • Lung Cancer
  • (no location specified)
Sep 23, 2022

Called FINE-REAL to Learn More About Use of Drug Finerenone

Recruiting
  • Chronic Kidney Disease
  • Type 2 Diabetes Mellitus
  • Kerendia (Finerenone, BAY94-8862)
  • Huntsville, Alabama
  • +53 more
Aug 15, 2022

s Data From Routine Eye Examinations of Patients Participating

Completed
  • Diabetic Retinopathy
  • Finerenone (BAY94-8862)
  • Chula Vista, California
  • +61 more
Jun 24, 2022

Oncology Trial in United States (BAY94-9343, BAY94-9343 (Expansion), BAY94-9343 (1.8 mg/kg))

Completed
  • Oncology
  • New Haven, Connecticut
  • +7 more
Jul 6, 2021

Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)

Completed
Has Results
  • Lung Carcinoma
  • +2 more
  • Computed Tomography
  • +5 more
  • Nashville, Tennessee
  • +1 more
Oct 17, 2022

Late Onset Alzheimer Trial in New York (BAY 94-9172 (Florbetaben))

Active, not recruiting
  • Late Onset Alzheimer Disease
  • BAY 94-9172 (Florbetaben)
  • New York, New York
    Columbia University Medical Center
Feb 11, 2022

Chronic Kidney Disease, Type 2 Diabetes Trial in Worldwide (Finerenone (BAY94-8862), Placebo)

Completed
  • Chronic Kidney Disease
  • Type 2 Diabetes Mellitus
  • Finerenone (BAY94-8862)
  • Placebo
  • Northridge, California
  • +114 more
Jan 9, 2022

Treatment of Bleeding, Prophylaxis of Bleeding, Hemophilia A Trial in Worldwide (Damoctocog alfa pegol (Jivi, BAY94-9027))

Recruiting
  • Treatment of Bleeding
  • +3 more
  • Damoctocog alfa pegol (Jivi, BAY94-9027)
  • Sacramento, California
  • +32 more
Aug 12, 2022

Called JOIHA to Learn More About How Well Treatment With Jivi

Recruiting
  • Hemophilia A
  • Prophylaxis of Bleeding
  • Damoctocog alfa pegol (Jivi, BAY94-9027)
  • Multiple Locations, Italy
    Many Locations
Jan 24, 2023

Hemophilia A Trial in Worldwide (Damoctocog alfa pegol (Jivi, BAY94-9027))

Completed
  • Hemophilia A
  • Damoctocog alfa pegol (Jivi, BAY94-9027)
  • Sofia, Bulgaria
  • +12 more
Feb 1, 2023

RAS Wild Type, Stage IV Colorectal Cancer, Stage IVA Colorectal Cancer Trial in Houston (Carbon C 11 Glutamine, Fluorine F 18

Recruiting
  • RAS Wild Type
  • +3 more
  • Carbon C 11 Glutamine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022